knowledge -WSS

knowledge

author：leisure time 2025-10-01 06:01:24 - browse：3

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Home health providers sue Medicare over payment cuts

WSS

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Biden’s NIH nominee is languishing in Congress

Why some people catch Covid but never get sick

Medicare wants to send $9 billion to 340B hospitals

The aspartame in Diet Coke probably isn’t giving you cancer

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

knowledge

Wikipedia

New air purifier tech could be key to improving indoor air quality

ACA's risk program benefits Blue Cross Blue Shield insurers

Psychedelics group wrestles with new pharma identity

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

FDA approval of Sarepta Duchenne genetic therapy gives me hope

White House announces new plan to address the growing threat of xylazine in overdose crisis

Tori Bowie and the unacceptable rates of Black maternal death

Biden declares emergency in flood

Anesthesiologist group: stop taking Ozempic before surgery

Parents surprise family after baby discharged from NICU after 170 days

leisure time

Stanford updates investigation of president’s past research

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Celebrate National Dole Whip Day for 3 days this week at Disney

ACA's risk program benefits Blue Cross Blue Shield insurers

White House announces new plan to address the growing threat of xylazine in overdose crisis

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

entertainment

focus

knowledge

focus